Aduhelm Label Update Includes Seizure Risk And Recommends More MRIs
FDA updated the prescribing information for Biogen’s Alzheimer's therapy after four cases of seizures were reported.
FDA updated the prescribing information for Biogen’s Alzheimer's therapy after four cases of seizures were reported.